Development of a visual tool to assess six dimensions of health and its validation in patients with endocrine disorders.
Biopsychosocial model
Endocrinology
Medical encounter
Psychosomatic assessment
Visual analogue scale
Journal
Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
14
09
2020
accepted:
05
01
2021
pubmed:
5
2
2021
medline:
31
8
2022
entrez:
4
2
2021
Statut:
ppublish
Résumé
Psychosocial factors significantly influence patient care in many fields of medicine, among these in the field of endocrinology. Easily applicable validated assessment tools for such psychosocial factors are lacking. Visual instruments may facilitate doctor-patient communication. This study describes the development and validation of a multidimensional visual tool for the self-assessment of health. An expert panel performed the multistep development of the psychosomatic assessment health disc (PAHD). Assessment of face validity was performed by means of a focus group of medical doctors (n = 6) and patient interviews (n = 24). For determining test-retest reliability, internal consistency and construct validity, patients of an endocrine outpatient clinic in Graz, Austria, completed the PAHD and the following questionnaires: short-form 36 health survey, work ability index, Pittsburgh sleep quality index and the social life scales of the life satisfaction questionnaire. A numeric six-item analogue scale was developed in the form of a disc. It addresses the following aspects of health: physical well-being, social life, sexuality, mental well-being, sleep, working ability/performance. For the validation process, 177 patients (57.1% females) participated in the study. Correlation coefficients of the six items with other questionnaires ranged between r = 0.51 (social life) and r = 0.72 (sleep). Test-retest reliability was assessed among 98 patients and was ≥ 0.74 for all 6 items, while Cronbach's alpha was 0.78. The psychometric properties of the PAHD support its use in clinical encounters with patients suffering from endocrine disorders. Further validation studies may be required to extend its application to other fields of medicine.
Sections du résumé
BACKGROUND
BACKGROUND
Psychosocial factors significantly influence patient care in many fields of medicine, among these in the field of endocrinology. Easily applicable validated assessment tools for such psychosocial factors are lacking. Visual instruments may facilitate doctor-patient communication. This study describes the development and validation of a multidimensional visual tool for the self-assessment of health.
METHODS
METHODS
An expert panel performed the multistep development of the psychosomatic assessment health disc (PAHD). Assessment of face validity was performed by means of a focus group of medical doctors (n = 6) and patient interviews (n = 24). For determining test-retest reliability, internal consistency and construct validity, patients of an endocrine outpatient clinic in Graz, Austria, completed the PAHD and the following questionnaires: short-form 36 health survey, work ability index, Pittsburgh sleep quality index and the social life scales of the life satisfaction questionnaire.
RESULTS
RESULTS
A numeric six-item analogue scale was developed in the form of a disc. It addresses the following aspects of health: physical well-being, social life, sexuality, mental well-being, sleep, working ability/performance. For the validation process, 177 patients (57.1% females) participated in the study. Correlation coefficients of the six items with other questionnaires ranged between r = 0.51 (social life) and r = 0.72 (sleep). Test-retest reliability was assessed among 98 patients and was ≥ 0.74 for all 6 items, while Cronbach's alpha was 0.78.
CONCLUSION
CONCLUSIONS
The psychometric properties of the PAHD support its use in clinical encounters with patients suffering from endocrine disorders. Further validation studies may be required to extend its application to other fields of medicine.
Identifiants
pubmed: 33538897
doi: 10.1007/s00508-021-01809-y
pii: 10.1007/s00508-021-01809-y
pmc: PMC9418290
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
569-580Informations de copyright
© 2021. The Author(s).
Références
J Clin Endocrinol Metab. 2015 Nov;100(11):3975-4011
pubmed: 26444994
JAMA Netw Open. 2020 Jul 1;3(7):e209644
pubmed: 32735338
Pituitary. 2017 Feb;20(1):185-188
pubmed: 27730455
Panminerva Med. 2010 Sep;52(3):249-64
pubmed: 21045782
Ann Intern Med. 2011 Jul 19;155(2):97-107
pubmed: 21768583
Psychiatry Res. 2000 Dec 27;97(2-3):165-72
pubmed: 11166088
Psychother Psychosom. 2012;81(1):1-4
pubmed: 22116166
J Dermatolog Treat. 2004 Jun;15(3):182-4
pubmed: 15204152
Endocr Pract. 2019 Nov;25(11):1191-1232
pubmed: 31760824
Occup Med (Lond). 2001 Aug;51(5):318-24
pubmed: 11473138
Occup Med (Lond). 2002 Jun;52(4):177-81
pubmed: 12091582
Med Care. 2009 Aug;47(8):826-34
pubmed: 19584762
Int J Impot Res. 2019 Nov;31(6):380-391
pubmed: 30918363
J Psychosom Res. 1998 Jul;45(1):5-13
pubmed: 9720850
Science. 1977 Apr 8;196(4286):129-36
pubmed: 847460
Qual Life Res. 2018 May;27(5):1171-1179
pubmed: 29260445
J Eur Acad Dermatol Venereol. 2015 Apr;29(4):725-31
pubmed: 25229692
Acad Med. 2016 May;91(5):657-62
pubmed: 26630603
PLoS One. 2016 May 23;11(5):e0156284
pubmed: 27214024
Neuroendocrinology. 2014;100(4):278-87
pubmed: 25427939
Adv Psychosom Med. 2012;32:1-18
pubmed: 22056895
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Adv Psychosom Med. 2007;28:21-33
pubmed: 17684318
Qual Life Res. 2010 May;19(4):539-49
pubmed: 20169472
J Eur Acad Dermatol Venereol. 2012 Sep;26(9):1163-6
pubmed: 21819450
J Fam Pract. 2000 Sep;49(9):796-804
pubmed: 11032203
Ann Fam Med. 2004 Nov-Dec;2(6):576-82
pubmed: 15576544
Psychother Psychosom. 2017;86(5):257-259
pubmed: 28903100
Psychoneuroendocrinology. 2019 Dec;110:104438
pubmed: 31563038
J Eur Acad Dermatol Venereol. 2019 Apr;33(4):766-773
pubmed: 30633405
J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744
pubmed: 29562364
J Clin Endocrinol Metab. 2016 Feb;101(2):364-89
pubmed: 26760044
J Am Board Fam Med. 2006 Nov-Dec;19(6):557-65
pubmed: 17090789